Rank | Gene Set | Z-score |
---|---|---|
1 | COPI coating of Golgi vesicle (GO:0048205) | 5.68066485 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.68066485 |
3 | NADH metabolic process (GO:0006734) | 3.91645649 |
4 | succinate metabolic process (GO:0006105) | 3.85937331 |
5 | protein localization to endosome (GO:0036010) | 3.79196096 |
6 | desmosome organization (GO:0002934) | 3.60605740 |
7 | positive regulation of vesicle fusion (GO:0031340) | 3.60307164 |
8 | tricarboxylic acid cycle (GO:0006099) | 3.51623174 |
9 | oxaloacetate metabolic process (GO:0006107) | 3.51196788 |
10 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.46213947 |
11 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.44710822 |
12 | macroautophagy (GO:0016236) | 3.42380716 |
13 | COPII vesicle coating (GO:0048208) | 3.35859575 |
14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29893314 |
15 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.28522990 |
16 | protein maturation by protein folding (GO:0022417) | 3.22774033 |
17 | hepatocyte apoptotic process (GO:0097284) | 3.22486265 |
18 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.20806610 |
19 | hemidesmosome assembly (GO:0031581) | 3.11099050 |
20 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08022502 |
21 | transferrin transport (GO:0033572) | 3.07981547 |
22 | sphingosine metabolic process (GO:0006670) | 3.07757948 |
23 | nuclear pore complex assembly (GO:0051292) | 3.06469132 |
24 | definitive hemopoiesis (GO:0060216) | 3.04662580 |
25 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.04285550 |
26 | trivalent inorganic cation transport (GO:0072512) | 3.01857246 |
27 | ferric iron transport (GO:0015682) | 3.01857246 |
28 | protein retention in ER lumen (GO:0006621) | 3.00312241 |
29 | positive regulation of interferon-alpha production (GO:0032727) | 2.99787049 |
30 | lysine metabolic process (GO:0006553) | 2.97578005 |
31 | lysine catabolic process (GO:0006554) | 2.97578005 |
32 | membrane raft organization (GO:0031579) | 2.97268113 |
33 | positive regulation of macroautophagy (GO:0016239) | 2.92515646 |
34 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.92258594 |
35 | intestinal epithelial cell development (GO:0060576) | 2.91498326 |
36 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.91494373 |
37 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.91232029 |
38 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.91232029 |
39 | hypotonic response (GO:0006971) | 2.90258806 |
40 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.84530802 |
41 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.84431005 |
42 | tricarboxylic acid metabolic process (GO:0072350) | 2.82935806 |
43 | regulation of interferon-alpha production (GO:0032647) | 2.80875698 |
44 | valine metabolic process (GO:0006573) | 2.79724093 |
45 | iron ion import (GO:0097286) | 2.79541624 |
46 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.77046885 |
47 | vesicle coating (GO:0006901) | 2.76405559 |
48 | negative regulation of alcohol biosynthetic process (GO:1902931) | 2.76298473 |
49 | sequestering of metal ion (GO:0051238) | 2.75971966 |
50 | regulation of glucokinase activity (GO:0033131) | 2.75869405 |
51 | regulation of hexokinase activity (GO:1903299) | 2.75869405 |
52 | protein targeting to Golgi (GO:0000042) | 2.71582754 |
53 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.70720753 |
54 | insulin secretion (GO:0030073) | 2.69819859 |
55 | phagosome maturation (GO:0090382) | 2.69538395 |
56 | cellular response to arsenic-containing substance (GO:0071243) | 2.69004102 |
57 | positive regulation of glycolytic process (GO:0045821) | 2.67839118 |
58 | diol metabolic process (GO:0034311) | 2.67492020 |
59 | cell adhesion mediated by integrin (GO:0033627) | 2.66721294 |
60 | drug transmembrane transport (GO:0006855) | 2.65076014 |
61 | glycoside metabolic process (GO:0016137) | 2.64812583 |
62 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.62924607 |
63 | signal peptide processing (GO:0006465) | 2.61939049 |
64 | early endosome to late endosome transport (GO:0045022) | 2.60907300 |
65 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.60051189 |
66 | positive regulation of protein autophosphorylation (GO:0031954) | 2.59303642 |
67 | histamine secretion (GO:0001821) | 2.58820584 |
68 | peptide hormone processing (GO:0016486) | 2.58688876 |
69 | regulation of protein localization to plasma membrane (GO:1903076) | 2.57880631 |
70 | Golgi organization (GO:0007030) | 2.56811047 |
71 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.55785479 |
72 | positive regulation of muscle hypertrophy (GO:0014742) | 2.55785479 |
73 | N-acetylneuraminate metabolic process (GO:0006054) | 2.55541093 |
74 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.53735604 |
75 | establishment of protein localization to Golgi (GO:0072600) | 2.53547770 |
76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.52106503 |
77 | glycosphingolipid catabolic process (GO:0046479) | 2.51696966 |
78 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.51157657 |
79 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.48447548 |
80 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.47905724 |
81 | response to arsenic-containing substance (GO:0046685) | 2.47563019 |
82 | negative regulation of hormone metabolic process (GO:0032351) | 2.47180455 |
83 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.47180455 |
84 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.47091262 |
85 | regulation of vitamin metabolic process (GO:0030656) | 2.46441974 |
86 | oligosaccharide catabolic process (GO:0009313) | 2.45898642 |
87 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.44226654 |
88 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.43563881 |
89 | positive regulation of macrophage differentiation (GO:0045651) | 2.43521990 |
90 | ER overload response (GO:0006983) | 2.42713462 |
91 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.41505393 |
92 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.41213422 |
93 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.41061115 |
94 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.41061115 |
95 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.40790809 |
96 | mammary gland epithelial cell proliferation (GO:0033598) | 2.40482152 |
97 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.40362009 |
98 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.39105437 |
99 | nuclear pore organization (GO:0006999) | 2.38544951 |
100 | negative regulation of type 2 immune response (GO:0002829) | 2.38444367 |
101 | Golgi to plasma membrane protein transport (GO:0043001) | 2.38429085 |
102 | response to thyroid hormone (GO:0097066) | 2.38191297 |
103 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.37953622 |
104 | skin morphogenesis (GO:0043589) | 2.36428585 |
105 | negative regulation of interleukin-17 production (GO:0032700) | 2.35708552 |
106 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.35600137 |
107 | pore complex assembly (GO:0046931) | 2.34459726 |
108 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.34016288 |
109 | regulation of coenzyme metabolic process (GO:0051196) | 2.33789939 |
110 | regulation of cofactor metabolic process (GO:0051193) | 2.33789939 |
111 | negative regulation of acute inflammatory response (GO:0002674) | 2.33490309 |
112 | mitotic sister chromatid cohesion (GO:0007064) | 2.32695733 |
113 | pH reduction (GO:0045851) | 2.32682183 |
114 | protein localization to Golgi apparatus (GO:0034067) | 2.32675805 |
115 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.31274334 |
116 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.31274334 |
117 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.30670091 |
118 | regulation of early endosome to late endosome transport (GO:2000641) | 2.30364223 |
119 | regulation of interferon-beta production (GO:0032648) | 2.29895201 |
120 | sphingoid metabolic process (GO:0046519) | 2.29283310 |
121 | regulation of histone H3-K27 methylation (GO:0061085) | 2.28764820 |
122 | glycolipid catabolic process (GO:0019377) | 2.28259844 |
123 | detection of calcium ion (GO:0005513) | 2.27884541 |
124 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.27568196 |
125 | positive regulation of response to nutrient levels (GO:0032109) | 2.25933204 |
126 | positive regulation of response to extracellular stimulus (GO:0032106) | 2.25933204 |
127 | toxin metabolic process (GO:0009404) | 2.25772250 |
128 | regulation of synaptic vesicle transport (GO:1902803) | 2.25651445 |
129 | negative regulation of anoikis (GO:2000811) | 2.25622987 |
130 | surfactant homeostasis (GO:0043129) | 2.25575782 |
131 | positive regulation of autophagy (GO:0010508) | 2.25213308 |
132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.25020217 |
133 | serotonin metabolic process (GO:0042428) | 2.24927160 |
134 | response to hydroperoxide (GO:0033194) | 2.24497693 |
135 | ribosome assembly (GO:0042255) | 2.23400521 |
136 | carnitine metabolic process (GO:0009437) | 2.23271924 |
137 | necroptotic process (GO:0070266) | 2.23052156 |
138 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.22448356 |
139 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.21778814 |
140 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.21778814 |
141 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.21551125 |
142 | primary amino compound metabolic process (GO:1901160) | 2.21394500 |
143 | sphingomyelin metabolic process (GO:0006684) | 2.20738092 |
144 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.20308138 |
145 | alkaloid metabolic process (GO:0009820) | 2.20007534 |
146 | negative regulation of cation channel activity (GO:2001258) | 2.19646776 |
147 | eosinophil chemotaxis (GO:0048245) | 2.19551196 |
148 | intracellular pH reduction (GO:0051452) | 2.19549931 |
149 | regulation of cholesterol homeostasis (GO:2000188) | 2.19063338 |
150 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.18332734 |
151 | cell-substrate junction assembly (GO:0007044) | 2.18171231 |
152 | lactate metabolic process (GO:0006089) | 2.17992451 |
153 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.17528002 |
154 | fatty acid homeostasis (GO:0055089) | 2.17374746 |
155 | histone H2B ubiquitination (GO:0033523) | 2.17336442 |
156 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.16884814 |
157 | serine transport (GO:0032329) | 2.16318037 |
158 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.16282428 |
159 | positive regulation of nuclease activity (GO:0032075) | 2.16253848 |
160 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.16232177 |
161 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.15986771 |
162 | neutrophil activation involved in immune response (GO:0002283) | 2.15236854 |
163 | response to peptidoglycan (GO:0032494) | 2.14940590 |
164 | energy homeostasis (GO:0097009) | 2.14096899 |
165 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.13572380 |
166 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.13469861 |
167 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.13136028 |
168 | inositol phosphate catabolic process (GO:0071545) | 2.13102925 |
169 | glutamate secretion (GO:0014047) | 2.12669791 |
170 | Golgi to plasma membrane transport (GO:0006893) | 2.12294377 |
171 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.12230548 |
172 | Golgi vesicle transport (GO:0048193) | 2.12082793 |
173 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.11750314 |
174 | cellular response to topologically incorrect protein (GO:0035967) | 2.11138966 |
175 | Golgi to endosome transport (GO:0006895) | 2.11063494 |
176 | cellular response to unfolded protein (GO:0034620) | 2.10314737 |
177 | cellular response to exogenous dsRNA (GO:0071360) | 2.09818662 |
178 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.09577749 |
179 | endocrine pancreas development (GO:0031018) | 2.09451622 |
180 | ER-nucleus signaling pathway (GO:0006984) | 2.09211319 |
181 | inositol phosphate dephosphorylation (GO:0046855) | 2.09050197 |
182 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.09050197 |
183 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.08930294 |
184 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.07314215 |
185 | gluconeogenesis (GO:0006094) | 2.07176161 |
186 | cellular response to ethanol (GO:0071361) | 2.06549417 |
187 | cellular response to nutrient (GO:0031670) | 2.06333361 |
188 | plasma membrane repair (GO:0001778) | 2.03237586 |
189 | regulation of insulin secretion (GO:0050796) | 2.03209664 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.58353176 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.26545909 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.03178133 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.95886989 |
5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.89100965 |
6 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.75034719 |
7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.64613584 |
8 | GATA1_22025678_ChIP-Seq_K562_Human | 2.61902481 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.47142567 |
10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.42767152 |
11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.29454976 |
12 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21105264 |
13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05548591 |
14 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.04081810 |
15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02974451 |
16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.02072941 |
17 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.01806603 |
18 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.01806603 |
19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.99046580 |
20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97954044 |
21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.94679026 |
22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.91029144 |
23 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.91029144 |
24 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77399474 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.71068881 |
26 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.71016155 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.68562539 |
28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.67336733 |
29 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.66426960 |
30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.65811946 |
31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.64095561 |
32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.64002649 |
33 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.60310009 |
34 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.60249869 |
35 | * MYB_26560356_Chip-Seq_TH2_Human | 1.50098691 |
36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49748578 |
37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49382901 |
38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48721989 |
39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46313208 |
40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42488324 |
41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42345864 |
42 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.42255220 |
43 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41910353 |
44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40185124 |
45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.40007547 |
46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37004903 |
47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.36833035 |
48 | MYB_26560356_Chip-Seq_TH1_Human | 1.36520205 |
49 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36452739 |
50 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.36399280 |
51 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.35207833 |
52 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33463075 |
53 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.33123332 |
54 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32095673 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.31848644 |
56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.31794323 |
57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30941818 |
58 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.30205518 |
59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28006396 |
60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25152327 |
61 | RXR_22108803_ChIP-Seq_LS180_Human | 1.24323423 |
62 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23293438 |
63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21228557 |
64 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.19136044 |
65 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18657526 |
66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18192643 |
67 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17758457 |
68 | VDR_22108803_ChIP-Seq_LS180_Human | 1.17586720 |
69 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.17080669 |
70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14415161 |
71 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13922213 |
72 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.13446232 |
73 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12885599 |
74 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.12883879 |
75 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.12067071 |
76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11982714 |
77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.10421263 |
78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09734764 |
79 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08961879 |
80 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08626617 |
81 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08383916 |
82 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08184504 |
83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08103158 |
84 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07963466 |
85 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.07461883 |
86 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.06960552 |
87 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.06090451 |
88 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05965490 |
89 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.05961222 |
90 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05100899 |
91 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.04984440 |
92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04772428 |
93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.04227144 |
94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02912213 |
95 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.02570637 |
96 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02416839 |
97 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.02382560 |
98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01952789 |
99 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01878870 |
100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01441015 |
101 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01186268 |
102 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00862898 |
103 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00505943 |
104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99817419 |
105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98997575 |
106 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.98601119 |
107 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.97990806 |
108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97656849 |
109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97613770 |
110 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.97406049 |
111 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.97375510 |
112 | SPI1_23127762_ChIP-Seq_K562_Human | 0.97318498 |
113 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95864922 |
114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95864922 |
115 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95410228 |
116 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.95144593 |
117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94992906 |
118 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.94737725 |
119 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94167507 |
120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93735883 |
121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.92667814 |
122 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.91594310 |
123 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.91556286 |
124 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91373150 |
125 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91282440 |
126 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90918369 |
127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.90857866 |
128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.90621160 |
129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.88738244 |
130 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.88456474 |
131 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87844829 |
132 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87219291 |
133 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86960750 |
134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.86398041 |
135 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.86337105 |
136 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85661564 |
137 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.84871043 |
138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83416317 |
139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82590295 |
140 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82440013 |
141 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.82346605 |
142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81917858 |
143 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.81616677 |
144 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81542651 |
145 | GATA3_26560356_Chip-Seq_TH1_Human | 0.81147785 |
146 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.80658079 |
147 | AR_20517297_ChIP-Seq_VCAP_Human | 0.80341149 |
148 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.80279527 |
149 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80245994 |
150 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78818365 |
151 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78619521 |
152 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.78612259 |
153 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.75993233 |
154 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75936182 |
155 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75061548 |
156 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.74349973 |
157 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73648484 |
158 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.73349383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 3.71412811 |
2 | MP0003195_calcinosis | 3.19941406 |
3 | MP0000013_abnormal_adipose_tissue | 3.04115631 |
4 | MP0010234_abnormal_vibrissa_follicle | 2.96034227 |
5 | MP0009780_abnormal_chondrocyte_physiolo | 2.77216432 |
6 | MP0002877_abnormal_melanocyte_morpholog | 2.75958550 |
7 | MP0010352_gastrointestinal_tract_polyps | 2.72561348 |
8 | MP0002909_abnormal_adrenal_gland | 2.59733014 |
9 | MP0005451_abnormal_body_composition | 2.52461759 |
10 | MP0010386_abnormal_urinary_bladder | 2.43906468 |
11 | MP0002139_abnormal_hepatobiliary_system | 2.40395330 |
12 | MP0002166_altered_tumor_susceptibility | 2.39419443 |
13 | MP0004043_abnormal_pH_regulation | 2.37594209 |
14 | MP0010678_abnormal_skin_adnexa | 2.22939685 |
15 | MP0003252_abnormal_bile_duct | 2.18734238 |
16 | MP0005058_abnormal_lysosome_morphology | 2.03992884 |
17 | MP0003656_abnormal_erythrocyte_physiolo | 2.03356510 |
18 | MP0003183_abnormal_peptide_metabolism | 2.00260613 |
19 | MP0002693_abnormal_pancreas_physiology | 1.96882268 |
20 | MP0005360_urolithiasis | 1.96046808 |
21 | MP0003879_abnormal_hair_cell | 1.95670704 |
22 | MP0002009_preneoplasia | 1.92302140 |
23 | MP0002876_abnormal_thyroid_physiology | 1.91022682 |
24 | MP0003763_abnormal_thymus_physiology | 1.86829244 |
25 | MP0005365_abnormal_bile_salt | 1.85813364 |
26 | MP0003453_abnormal_keratinocyte_physiol | 1.84585130 |
27 | MP0002006_tumorigenesis | 1.82733566 |
28 | MP0001765_abnormal_ion_homeostasis | 1.80896673 |
29 | MP0004130_abnormal_muscle_cell | 1.78070133 |
30 | MP0001944_abnormal_pancreas_morphology | 1.76147443 |
31 | MP0008057_abnormal_DNA_replication | 1.68951433 |
32 | MP0000383_abnormal_hair_follicle | 1.66514678 |
33 | MP0003950_abnormal_plasma_membrane | 1.65218970 |
34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.64285891 |
35 | MP0004381_abnormal_hair_follicle | 1.56315453 |
36 | MP0003300_gastrointestinal_ulcer | 1.55940132 |
37 | MP0003091_abnormal_cell_migration | 1.53477260 |
38 | MP0005332_abnormal_amino_acid | 1.52802334 |
39 | MP0005084_abnormal_gallbladder_morpholo | 1.50757869 |
40 | MP0004036_abnormal_muscle_relaxation | 1.49244381 |
41 | MP0002078_abnormal_glucose_homeostasis | 1.47616069 |
42 | MP0003172_abnormal_lysosome_physiology | 1.46212452 |
43 | MP0005535_abnormal_body_temperature | 1.45565899 |
44 | MP0005220_abnormal_exocrine_pancreas | 1.42886202 |
45 | MP0008260_abnormal_autophagy | 1.42848201 |
46 | MP0009643_abnormal_urine_homeostasis | 1.40915068 |
47 | MP0005310_abnormal_salivary_gland | 1.40789257 |
48 | MP0005085_abnormal_gallbladder_physiolo | 1.39914361 |
49 | MP0000427_abnormal_hair_cycle | 1.35759640 |
50 | MP0000749_muscle_degeneration | 1.33845062 |
51 | MP0001216_abnormal_epidermal_layer | 1.32269826 |
52 | MP0003646_muscle_fatigue | 1.31929926 |
53 | MP0003329_amyloid_beta_deposits | 1.31701201 |
54 | MP0005636_abnormal_mineral_homeostasis | 1.31017816 |
55 | MP0004782_abnormal_surfactant_physiolog | 1.30704879 |
56 | MP0009046_muscle_twitch | 1.30145215 |
57 | MP0008004_abnormal_stomach_pH | 1.29375167 |
58 | MP0010329_abnormal_lipoprotein_level | 1.27909881 |
59 | MP0004264_abnormal_extraembryonic_tissu | 1.27729454 |
60 | MP0002060_abnormal_skin_morphology | 1.27527224 |
61 | MP0003045_fibrosis | 1.26491823 |
62 | MP0000685_abnormal_immune_system | 1.23990588 |
63 | MP0003828_pulmonary_edema | 1.23931845 |
64 | MP0010155_abnormal_intestine_physiology | 1.23820826 |
65 | MP0002796_impaired_skin_barrier | 1.21963740 |
66 | MP0003724_increased_susceptibility_to | 1.21225581 |
67 | MP0002332_abnormal_exercise_endurance | 1.19416168 |
68 | MP0004947_skin_inflammation | 1.18367633 |
69 | MP0004084_abnormal_cardiac_muscle | 1.17542137 |
70 | MP0000604_amyloidosis | 1.15669817 |
71 | MP0003303_peritoneal_inflammation | 1.15441441 |
72 | MP0001800_abnormal_humoral_immune | 1.14965085 |
73 | MP0004808_abnormal_hematopoietic_stem | 1.14080849 |
74 | MP0001835_abnormal_antigen_presentation | 1.12437973 |
75 | MP0009785_altered_susceptibility_to | 1.12317681 |
76 | MP0002396_abnormal_hematopoietic_system | 1.12026537 |
77 | MP0002723_abnormal_immune_serum | 1.11760104 |
78 | MP0005621_abnormal_cell_physiology | 1.11638217 |
79 | MP0002452_abnormal_antigen_presenting | 1.11408717 |
80 | MP0003436_decreased_susceptibility_to | 1.10061205 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 1.09681632 |
82 | MP0001661_extended_life_span | 1.08920172 |
83 | MP0001501_abnormal_sleep_pattern | 1.07894457 |
84 | MP0000465_gastrointestinal_hemorrhage | 1.07566106 |
85 | MP0002928_abnormal_bile_duct | 1.06125392 |
86 | MP0003448_altered_tumor_morphology | 1.04909264 |
87 | MP0000003_abnormal_adipose_tissue | 1.04395471 |
88 | MP0006036_abnormal_mitochondrial_physio | 1.04390666 |
89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03721342 |
90 | MP0001756_abnormal_urination | 1.03595142 |
91 | MP0002398_abnormal_bone_marrow | 1.03333067 |
92 | MP0005076_abnormal_cell_differentiation | 1.02757428 |
93 | MP0001533_abnormal_skeleton_physiology | 1.01567195 |
94 | MP0005075_abnormal_melanosome_morpholog | 1.00686965 |
95 | MP0002420_abnormal_adaptive_immunity | 0.99876811 |
96 | MP0001819_abnormal_immune_cell | 0.99619442 |
97 | MP0000858_altered_metastatic_potential | 0.99459270 |
98 | MP0000609_abnormal_liver_physiology | 0.98513765 |
99 | MP0005166_decreased_susceptibility_to | 0.97654117 |
100 | MP0000230_abnormal_systemic_arterial | 0.97501792 |
101 | MP0005379_endocrine/exocrine_gland_phen | 0.97391446 |
102 | MP0001191_abnormal_skin_condition | 0.97289175 |
103 | MP0009764_decreased_sensitivity_to | 0.97226013 |
104 | MP0008469_abnormal_protein_level | 0.96371862 |
105 | MP0010307_abnormal_tumor_latency | 0.95462936 |
106 | MP0002118_abnormal_lipid_homeostasis | 0.95404704 |
107 | MP0000751_myopathy | 0.95299278 |
108 | MP0002138_abnormal_hepatobiliary_system | 0.94501431 |
109 | MP0001845_abnormal_inflammatory_respons | 0.94443252 |
110 | MP0002419_abnormal_innate_immunity | 0.92172432 |
111 | MP0005000_abnormal_immune_tolerance | 0.89358711 |
112 | MP0003191_abnormal_cellular_cholesterol | 0.88824534 |
113 | MP0009333_abnormal_splenocyte_physiolog | 0.88620387 |
114 | MP0005448_abnormal_energy_balance | 0.88600035 |
115 | MP0001851_eye_inflammation | 0.88163545 |
116 | MP0009384_cardiac_valve_regurgitation | 0.86462079 |
117 | MP0008438_abnormal_cutaneous_collagen | 0.86322756 |
118 | MP0004147_increased_porphyrin_level | 0.86076545 |
119 | MP0000015_abnormal_ear_pigmentation | 0.86001232 |
120 | MP0001727_abnormal_embryo_implantation | 0.85834215 |
121 | MP0002998_abnormal_bone_remodeling | 0.84523341 |
122 | MP0002971_abnormal_brown_adipose | 0.84177385 |
123 | MP0003953_abnormal_hormone_level | 0.84004401 |
124 | MP0003705_abnormal_hypodermis_morpholog | 0.83424419 |
125 | MP0002168_other_aberrant_phenotype | 0.83061880 |
126 | MP0005384_cellular_phenotype | 0.83048435 |
127 | MP0002722_abnormal_immune_system | 0.82474460 |
128 | MP0005025_abnormal_response_to | 0.82370034 |
129 | MP0001666_abnormal_nutrient_absorption | 0.82161685 |
130 | MP0001243_abnormal_dermal_layer | 0.81905100 |
131 | MP0005165_increased_susceptibility_to | 0.81803764 |
132 | MP0000377_abnormal_hair_follicle | 0.81796220 |
133 | MP0005464_abnormal_platelet_physiology | 0.81766855 |
134 | MP0004185_abnormal_adipocyte_glucose | 0.81561370 |
135 | MP0001764_abnormal_homeostasis | 0.81382213 |
136 | MP0003075_altered_response_to | 0.81354515 |
137 | MP0002405_respiratory_system_inflammati | 0.81024428 |
138 | MP0009840_abnormal_foam_cell | 0.80699480 |
139 | MP0000689_abnormal_spleen_morphology | 0.80597781 |
140 | MP0000716_abnormal_immune_system | 0.80123421 |
141 | MP0002896_abnormal_bone_mineralization | 0.80050982 |
142 | MP0006082_CNS_inflammation | 0.79930322 |
143 | MP0005671_abnormal_response_to | 0.79143994 |
144 | MP0004510_myositis | 0.78846190 |
145 | MP0006054_spinal_hemorrhage | 0.78411136 |
146 | MP0003566_abnormal_cell_adhesion | 0.77906913 |
147 | MP0005387_immune_system_phenotype | 0.77273313 |
148 | MP0001790_abnormal_immune_system | 0.77273313 |
149 | MP0004859_abnormal_synaptic_plasticity | 0.77184214 |
150 | MP0000371_diluted_coat_color | 0.76685452 |
151 | MP0002148_abnormal_hypersensitivity_rea | 0.75765692 |
152 | MP0004215_abnormal_myocardial_fiber | 0.74316722 |
153 | MP0005083_abnormal_biliary_tract | 0.73652815 |
154 | MP0008874_decreased_physiological_sensi | 0.73158710 |
155 | MP0005375_adipose_tissue_phenotype | 0.73017398 |
156 | MP0003868_abnormal_feces_composition | 0.71828150 |
157 | MP0005275_abnormal_skin_tensile | 0.71769946 |
158 | MP0006035_abnormal_mitochondrial_morpho | 0.71762487 |
159 | MP0003866_abnormal_defecation | 0.71601462 |
160 | MP0003283_abnormal_digestive_organ | 0.71568405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoglycemic coma (HP:0001325) | 3.54164452 |
2 | Papillary thyroid carcinoma (HP:0002895) | 3.22336074 |
3 | Gout (HP:0001997) | 2.95511043 |
4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.92147628 |
5 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.89876343 |
6 | Ketoacidosis (HP:0001993) | 2.84854959 |
7 | Hypoglycemic seizures (HP:0002173) | 2.82760474 |
8 | Osteolytic defects of the hand bones (HP:0009699) | 2.78499878 |
9 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.78499878 |
10 | Oligomenorrhea (HP:0000876) | 2.77148058 |
11 | Hyperglycemia (HP:0003074) | 2.72959303 |
12 | Vacuolated lymphocytes (HP:0001922) | 2.70255838 |
13 | Generalized aminoaciduria (HP:0002909) | 2.68348498 |
14 | Dysostosis multiplex (HP:0000943) | 2.64065642 |
15 | Vertebral compression fractures (HP:0002953) | 2.62591701 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59526941 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59526941 |
18 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59526941 |
19 | Thyroid carcinoma (HP:0002890) | 2.59192459 |
20 | Thick nail (HP:0001805) | 2.58859362 |
21 | Horizontal nystagmus (HP:0000666) | 2.48259772 |
22 | Symptomatic seizures (HP:0011145) | 2.45318821 |
23 | Fatigue (HP:0012378) | 2.44288449 |
24 | Visual hallucinations (HP:0002367) | 2.41815137 |
25 | Hypercortisolism (HP:0001578) | 2.38774653 |
26 | Myoglobinuria (HP:0002913) | 2.38616366 |
27 | Increased mean platelet volume (HP:0011877) | 2.36946017 |
28 | Onycholysis (HP:0001806) | 2.33818487 |
29 | Curly hair (HP:0002212) | 2.33684876 |
30 | Basal ganglia calcification (HP:0002135) | 2.29749494 |
31 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.28599685 |
32 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.28599685 |
33 | Abnormal platelet volume (HP:0011876) | 2.27763564 |
34 | Milia (HP:0001056) | 2.27582753 |
35 | Abnormality of the intrinsic pathway (HP:0010989) | 2.27563885 |
36 | Autoamputation (HP:0001218) | 2.27510762 |
37 | Hypokinesia (HP:0002375) | 2.26649782 |
38 | Asymmetry of the thorax (HP:0001555) | 2.26048330 |
39 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.23124225 |
40 | Increased cerebral lipofuscin (HP:0011813) | 2.22909518 |
41 | Late onset (HP:0003584) | 2.22582161 |
42 | Plantar hyperkeratosis (HP:0007556) | 2.21784849 |
43 | Mucopolysacchariduria (HP:0008155) | 2.20686135 |
44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20686135 |
45 | Resting tremor (HP:0002322) | 2.19982305 |
46 | Dysmetric saccades (HP:0000641) | 2.19821284 |
47 | Acute hepatic failure (HP:0006554) | 2.18435459 |
48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18333500 |
49 | Testicular neoplasm (HP:0010788) | 2.17882839 |
50 | Short nail (HP:0001799) | 2.15533536 |
51 | Erythema (HP:0010783) | 2.15134875 |
52 | Ketosis (HP:0001946) | 2.14242895 |
53 | Focal motor seizures (HP:0011153) | 2.12498800 |
54 | Cardiovascular calcification (HP:0011915) | 2.12042045 |
55 | Petechiae (HP:0000967) | 2.11966576 |
56 | Sensorimotor neuropathy (HP:0007141) | 2.10467831 |
57 | Vascular calcification (HP:0004934) | 2.09115089 |
58 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08627863 |
59 | Cutaneous melanoma (HP:0012056) | 2.08130731 |
60 | Hematochezia (HP:0002573) | 2.06278485 |
61 | Autoimmune hemolytic anemia (HP:0001890) | 2.04159208 |
62 | Micronodular cirrhosis (HP:0001413) | 2.03653706 |
63 | Neuroendocrine neoplasm (HP:0100634) | 2.02952720 |
64 | Abnormality of purine metabolism (HP:0004352) | 2.02017632 |
65 | Mitral stenosis (HP:0001718) | 2.01740425 |
66 | Malnutrition (HP:0004395) | 2.01674176 |
67 | Subacute progressive viral hepatitis (HP:0006572) | 2.01142143 |
68 | Myocardial infarction (HP:0001658) | 2.00861127 |
69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00486199 |
70 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00486199 |
71 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00486199 |
72 | Alopecia of scalp (HP:0002293) | 1.98650997 |
73 | Eczematoid dermatitis (HP:0000976) | 1.98353149 |
74 | Chronic diarrhea (HP:0002028) | 1.96484866 |
75 | Absent frontal sinuses (HP:0002688) | 1.95644093 |
76 | Pheochromocytoma (HP:0002666) | 1.94141283 |
77 | Difficulty climbing stairs (HP:0003551) | 1.94050936 |
78 | Exercise-induced muscle cramps (HP:0003710) | 1.94050904 |
79 | Insidious onset (HP:0003587) | 1.93937500 |
80 | Termporal pattern (HP:0011008) | 1.93937500 |
81 | Abnormality of the basal ganglia (HP:0002134) | 1.93776192 |
82 | Atonic seizures (HP:0010819) | 1.93515415 |
83 | Palmoplantar hyperkeratosis (HP:0000972) | 1.92316383 |
84 | Abnormal glucose tolerance (HP:0001952) | 1.91379435 |
85 | Protuberant abdomen (HP:0001538) | 1.91026590 |
86 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89898129 |
87 | Gingival bleeding (HP:0000225) | 1.89773465 |
88 | Xanthomatosis (HP:0000991) | 1.89127157 |
89 | Conjunctival hamartoma (HP:0100780) | 1.88921324 |
90 | Coarse hair (HP:0002208) | 1.88013981 |
91 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.87511659 |
92 | Progressive neurologic deterioration (HP:0002344) | 1.85818265 |
93 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.85176856 |
94 | Global brain atrophy (HP:0002283) | 1.84052452 |
95 | Hypothermia (HP:0002045) | 1.83336994 |
96 | Palmar hyperkeratosis (HP:0010765) | 1.82955488 |
97 | Asymmetric septal hypertrophy (HP:0001670) | 1.82554379 |
98 | Abnormality of macrophages (HP:0004311) | 1.81919055 |
99 | Type I diabetes mellitus (HP:0100651) | 1.80137916 |
100 | Calf muscle hypertrophy (HP:0008981) | 1.79497392 |
101 | Overlapping toe (HP:0001845) | 1.79481512 |
102 | Interstitial pulmonary disease (HP:0006530) | 1.79193154 |
103 | Osteomyelitis (HP:0002754) | 1.79063765 |
104 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78051357 |
105 | Beaking of vertebral bodies (HP:0004568) | 1.77341151 |
106 | Prolonged bleeding time (HP:0003010) | 1.75945729 |
107 | Recurrent bacterial skin infections (HP:0005406) | 1.75838270 |
108 | Striae distensae (HP:0001065) | 1.75830038 |
109 | Lower limb hyperreflexia (HP:0002395) | 1.75636712 |
110 | Sparse lateral eyebrow (HP:0005338) | 1.74739198 |
111 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.74624601 |
112 | Tetraparesis (HP:0002273) | 1.74052796 |
113 | Growth hormone excess (HP:0000845) | 1.71983739 |
114 | Anhidrosis (HP:0000970) | 1.71931748 |
115 | Increased connective tissue (HP:0009025) | 1.71329761 |
116 | Progressive visual loss (HP:0000529) | 1.70654402 |
117 | Slow saccadic eye movements (HP:0000514) | 1.69855138 |
118 | Progressive hearing impairment (HP:0001730) | 1.69026075 |
119 | Tongue fasciculations (HP:0001308) | 1.68122433 |
120 | Cheilitis (HP:0100825) | 1.67554108 |
121 | Prominent metopic ridge (HP:0005487) | 1.67366326 |
122 | Acanthocytosis (HP:0001927) | 1.66743312 |
123 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66517025 |
124 | Hepatic necrosis (HP:0002605) | 1.66437219 |
125 | Loss of speech (HP:0002371) | 1.66021732 |
126 | Viral hepatitis (HP:0006562) | 1.65663309 |
127 | Shoulder girdle muscle weakness (HP:0003547) | 1.65200976 |
128 | Hyperphosphatemia (HP:0002905) | 1.65092587 |
129 | Central scotoma (HP:0000603) | 1.65080900 |
130 | Abnormality of nail color (HP:0100643) | 1.64827375 |
131 | Recurrent abscess formation (HP:0002722) | 1.64051528 |
132 | Septate vagina (HP:0001153) | 1.63985520 |
133 | Glucose intolerance (HP:0000833) | 1.63310274 |
134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.63286746 |
135 | Entropion (HP:0000621) | 1.62249345 |
136 | Epileptic encephalopathy (HP:0200134) | 1.61908274 |
137 | Syringomyelia (HP:0003396) | 1.61867991 |
138 | Spinal cord lesions (HP:0100561) | 1.61867991 |
139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.61738975 |
140 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.61735280 |
141 | Nail dystrophy (HP:0008404) | 1.61481846 |
142 | Chronic otitis media (HP:0000389) | 1.61350383 |
143 | Hyperventilation (HP:0002883) | 1.61061468 |
144 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.60710983 |
145 | Villous atrophy (HP:0011473) | 1.60710983 |
146 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.60686510 |
147 | Premature rupture of membranes (HP:0001788) | 1.60576280 |
148 | Unilateral renal agenesis (HP:0000122) | 1.60527427 |
149 | Cervical subluxation (HP:0003308) | 1.59735484 |
150 | Muscle fibrillation (HP:0010546) | 1.59622109 |
151 | Abnormal gallbladder morphology (HP:0012437) | 1.59068598 |
152 | Hypoventilation (HP:0002791) | 1.58967525 |
153 | Bundle branch block (HP:0011710) | 1.58442717 |
154 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.57870531 |
155 | Hyperparathyroidism (HP:0000843) | 1.57634195 |
156 | Absence seizures (HP:0002121) | 1.55655014 |
157 | Right ventricular cardiomyopathy (HP:0011663) | 1.55229494 |
158 | Pancreatitis (HP:0001733) | 1.52856694 |
159 | Menstrual irregularities (HP:0000858) | 1.51743073 |
160 | Hydroxyprolinuria (HP:0003080) | 1.51392584 |
161 | Abnormality of proline metabolism (HP:0010907) | 1.51392584 |
162 | Cholelithiasis (HP:0001081) | 1.51141353 |
163 | Esophageal neoplasm (HP:0100751) | 1.50838051 |
164 | Neoplasm of head and neck (HP:0012288) | 1.50838051 |
165 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.50595573 |
166 | Dicarboxylic aciduria (HP:0003215) | 1.50595573 |
167 | Abnormality of chloride homeostasis (HP:0011422) | 1.50584578 |
168 | Insulin resistance (HP:0000855) | 1.50516647 |
169 | Type II lissencephaly (HP:0007260) | 1.50069244 |
170 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.49757820 |
171 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.49594767 |
172 | Retinal atrophy (HP:0001105) | 1.49320913 |
173 | Conjugated hyperbilirubinemia (HP:0002908) | 1.49279072 |
174 | Abdominal distention (HP:0003270) | 1.48895853 |
175 | Biconcave vertebral bodies (HP:0004586) | 1.48314495 |
176 | Spinal canal stenosis (HP:0003416) | 1.48011303 |
177 | Pelvic girdle muscle weakness (HP:0003749) | 1.47920864 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 4.04139753 |
2 | RIPK4 | 3.63121240 |
3 | FRK | 3.47488843 |
4 | MST4 | 3.10598821 |
5 | CAMKK2 | 2.58895460 |
6 | INSRR | 2.47459171 |
7 | PDK4 | 2.44971814 |
8 | PDK3 | 2.44971814 |
9 | ARAF | 2.31263676 |
10 | TRIB3 | 2.17995503 |
11 | ERN1 | 2.13584034 |
12 | CASK | 1.98041349 |
13 | MAP3K14 | 1.91082364 |
14 | IRAK3 | 1.90118950 |
15 | MAP3K12 | 1.89451066 |
16 | BCKDK | 1.87738974 |
17 | MAP3K13 | 1.81107060 |
18 | BRD4 | 1.76755237 |
19 | EIF2AK1 | 1.76685182 |
20 | AKT3 | 1.76265031 |
21 | PRPF4B | 1.71277517 |
22 | STK24 | 1.68137060 |
23 | NTRK3 | 1.64745935 |
24 | PIM2 | 1.63664320 |
25 | MAP3K3 | 1.63047797 |
26 | FLT3 | 1.56937349 |
27 | FGFR3 | 1.46377115 |
28 | PDK2 | 1.44393336 |
29 | TTN | 1.42724159 |
30 | IRAK4 | 1.38883063 |
31 | STK3 | 1.36191981 |
32 | ERBB3 | 1.36189951 |
33 | JAK1 | 1.35149732 |
34 | ACVR1B | 1.34996249 |
35 | CDK12 | 1.30960075 |
36 | MYLK | 1.28859221 |
37 | BMPR2 | 1.24643008 |
38 | EPHA2 | 1.24267898 |
39 | PASK | 1.23388145 |
40 | CCNB1 | 1.22498797 |
41 | BRSK2 | 1.21843452 |
42 | NEK9 | 1.21061479 |
43 | SCYL2 | 1.19699099 |
44 | CAMKK1 | 1.19570092 |
45 | TRPM7 | 1.18721948 |
46 | CSF1R | 1.18191898 |
47 | WNK4 | 1.17172336 |
48 | MAP3K2 | 1.15789487 |
49 | PIK3CG | 1.14301236 |
50 | MELK | 1.10087358 |
51 | CDK19 | 1.08377250 |
52 | PRKD3 | 1.07121515 |
53 | TBK1 | 1.06853905 |
54 | BRAF | 1.05831515 |
55 | MARK3 | 1.04637541 |
56 | FER | 1.04148212 |
57 | TAOK1 | 1.02594621 |
58 | CDK6 | 1.02579933 |
59 | PLK2 | 1.02301335 |
60 | PKN2 | 1.02199656 |
61 | MAP2K7 | 1.01600909 |
62 | TSSK6 | 1.01566835 |
63 | TYK2 | 1.00786534 |
64 | NEK6 | 0.99979259 |
65 | IKBKB | 0.99458592 |
66 | BTK | 0.99258861 |
67 | DAPK2 | 0.99180522 |
68 | MAP3K1 | 0.96809307 |
69 | ABL2 | 0.94625127 |
70 | JAK3 | 0.93291105 |
71 | MUSK | 0.93132269 |
72 | PDGFRB | 0.91382024 |
73 | NLK | 0.91044640 |
74 | PDGFRA | 0.88634546 |
75 | PAK4 | 0.88266135 |
76 | IRAK1 | 0.85627771 |
77 | DAPK1 | 0.85279090 |
78 | TESK1 | 0.85253125 |
79 | STK38 | 0.84127041 |
80 | MET | 0.84071213 |
81 | STK10 | 0.82198277 |
82 | NEK1 | 0.81825957 |
83 | PTK2B | 0.81106156 |
84 | MAP2K3 | 0.80403934 |
85 | FGR | 0.80135046 |
86 | TGFBR2 | 0.79432764 |
87 | MAPK11 | 0.77450008 |
88 | NTRK1 | 0.77431793 |
89 | YES1 | 0.76999548 |
90 | GRK5 | 0.76818345 |
91 | CSK | 0.76411802 |
92 | MAP2K4 | 0.76320551 |
93 | RAF1 | 0.72820877 |
94 | STK38L | 0.71759543 |
95 | FGFR4 | 0.68343590 |
96 | JAK2 | 0.67805405 |
97 | MAP3K5 | 0.67204631 |
98 | PRKCH | 0.66350392 |
99 | PTK2 | 0.66231203 |
100 | PAK3 | 0.65572959 |
101 | TEC | 0.64655611 |
102 | SGK2 | 0.63373202 |
103 | LMTK2 | 0.62562600 |
104 | KIT | 0.62481799 |
105 | TXK | 0.62364928 |
106 | MAP3K4 | 0.61782460 |
107 | TIE1 | 0.61385362 |
108 | HCK | 0.61233638 |
109 | MAPKAPK3 | 0.60006890 |
110 | CHUK | 0.59687395 |
111 | PDK1 | 0.58891120 |
112 | SYK | 0.55765415 |
113 | SGK3 | 0.55228018 |
114 | MAP3K9 | 0.55160756 |
115 | FES | 0.54670264 |
116 | WNK1 | 0.54077967 |
117 | RET | 0.52874927 |
118 | MOS | 0.52520738 |
119 | EPHB1 | 0.51164272 |
120 | STK4 | 0.50032217 |
121 | IKBKE | 0.49978200 |
122 | PRKCE | 0.48909094 |
123 | RPS6KB1 | 0.48495785 |
124 | MAP2K1 | 0.47804343 |
125 | SIK3 | 0.46051521 |
126 | MAP3K7 | 0.44811901 |
127 | SIK1 | 0.44017890 |
128 | PTK6 | 0.43460509 |
129 | CDK9 | 0.43121121 |
130 | HIPK2 | 0.42494349 |
131 | EIF2AK3 | 0.41840163 |
132 | PDPK1 | 0.41136351 |
133 | ITK | 0.40716912 |
134 | RIPK1 | 0.40231207 |
135 | MAPK7 | 0.40126992 |
136 | ZAP70 | 0.40065773 |
137 | EPHA3 | 0.39571587 |
138 | EEF2K | 0.37415976 |
139 | WNK3 | 0.37222611 |
140 | LATS2 | 0.37181199 |
141 | MST1R | 0.36727630 |
142 | PIK3CA | 0.36319408 |
143 | KSR2 | 0.35363869 |
144 | PRKCQ | 0.32725750 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.44557887 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.43809115 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.92033980 |
4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.73921051 |
5 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.33910759 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19429508 |
7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.85576199 |
8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82221352 |
9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.80082941 |
10 | Protein export_Homo sapiens_hsa03060 | 1.78336817 |
11 | Insulin secretion_Homo sapiens_hsa04911 | 1.77270480 |
12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.66282354 |
13 | Measles_Homo sapiens_hsa05162 | 1.61662436 |
14 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.57229652 |
15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.56697867 |
16 | Thyroid cancer_Homo sapiens_hsa05216 | 1.56080439 |
17 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.53055348 |
18 | Other glycan degradation_Homo sapiens_hsa00511 | 1.45324995 |
19 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44628271 |
20 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41320920 |
21 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39057834 |
22 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37488792 |
23 | Prostate cancer_Homo sapiens_hsa05215 | 1.35659682 |
24 | Hepatitis C_Homo sapiens_hsa05160 | 1.35280842 |
25 | Hepatitis B_Homo sapiens_hsa05161 | 1.35155541 |
26 | Lysosome_Homo sapiens_hsa04142 | 1.34713865 |
27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.31332168 |
28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.30156404 |
29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.29796557 |
30 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.28955723 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.28757117 |
32 | Endometrial cancer_Homo sapiens_hsa05213 | 1.28057321 |
33 | Platelet activation_Homo sapiens_hsa04611 | 1.27044744 |
34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26516587 |
35 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26266994 |
36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.25985915 |
37 | Shigellosis_Homo sapiens_hsa05131 | 1.25489709 |
38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22991891 |
39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.22672490 |
40 | Influenza A_Homo sapiens_hsa05164 | 1.18289980 |
41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17959348 |
42 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.16898123 |
43 | Legionellosis_Homo sapiens_hsa05134 | 1.15971504 |
44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15740332 |
45 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.15341571 |
46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13904156 |
47 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13857667 |
48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.10183746 |
49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08968524 |
50 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.07748402 |
51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05253590 |
52 | Phagosome_Homo sapiens_hsa04145 | 1.02706290 |
53 | Phototransduction_Homo sapiens_hsa04744 | 1.01788778 |
54 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.01682671 |
55 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01418731 |
56 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00939138 |
57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98838177 |
58 | Long-term potentiation_Homo sapiens_hsa04720 | 0.98698524 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 0.97932085 |
60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.96471820 |
61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96129019 |
62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94912743 |
63 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94890595 |
64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.93588105 |
65 | Apoptosis_Homo sapiens_hsa04210 | 0.93563836 |
66 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.93146749 |
67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.92360627 |
68 | Tuberculosis_Homo sapiens_hsa05152 | 0.92118170 |
69 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87373720 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87300291 |
71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.86332939 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85584745 |
73 | Glioma_Homo sapiens_hsa05214 | 0.85401764 |
74 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83874732 |
75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83577417 |
76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.83038527 |
77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82789071 |
78 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.81380459 |
79 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.80548798 |
80 | Endocytosis_Homo sapiens_hsa04144 | 0.80383049 |
81 | Circadian entrainment_Homo sapiens_hsa04713 | 0.79280413 |
82 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78366472 |
83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77449981 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.77326945 |
85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.77218895 |
86 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.77161194 |
87 | Renin secretion_Homo sapiens_hsa04924 | 0.76554439 |
88 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.76329279 |
89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76176224 |
90 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.76171247 |
91 | Focal adhesion_Homo sapiens_hsa04510 | 0.75840169 |
92 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75118309 |
93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.74196348 |
94 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72164590 |
95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.71975082 |
96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71962594 |
97 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71101225 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69937257 |
99 | Salivary secretion_Homo sapiens_hsa04970 | 0.69212612 |
100 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68804086 |
101 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.68787767 |
102 | Amoebiasis_Homo sapiens_hsa05146 | 0.68301760 |
103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67395650 |
104 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66849851 |
105 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66840006 |
106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66391018 |
107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.66157330 |
108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65365362 |
109 | Bladder cancer_Homo sapiens_hsa05219 | 0.65010523 |
110 | GABAergic synapse_Homo sapiens_hsa04727 | 0.64091830 |
111 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63266262 |
112 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62993211 |
113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62509094 |
114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.61751659 |
115 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59904442 |
116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59594548 |
117 | Morphine addiction_Homo sapiens_hsa05032 | 0.58873599 |
118 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58723236 |
119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58659919 |
120 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58606350 |
121 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.57910100 |
122 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57018834 |
123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56125969 |
124 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55528274 |
125 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55130506 |
126 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54762863 |
127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54623082 |
128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.54268799 |
129 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53910052 |
130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53520178 |
131 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53043826 |
132 | Peroxisome_Homo sapiens_hsa04146 | 0.52712093 |
133 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52316489 |
134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52209310 |
135 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52204606 |
136 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51388456 |
137 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.51352616 |
138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51329737 |
139 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.50835072 |
140 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.50671320 |
141 | Adherens junction_Homo sapiens_hsa04520 | 0.50145919 |
142 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.50047633 |
143 | Bile secretion_Homo sapiens_hsa04976 | 0.49195405 |
144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49184942 |
145 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48311798 |
146 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47547048 |
147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46546765 |
148 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46421473 |
149 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45745134 |
150 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44505118 |
151 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.43574821 |
152 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42235930 |
153 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.41774984 |
154 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.41358068 |
155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40250540 |
156 | Nicotine addiction_Homo sapiens_hsa05033 | 0.39278671 |
157 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39172510 |
158 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37466551 |
159 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.37196770 |
160 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37143007 |
161 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.36270272 |
162 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.35421257 |